New effective treatments for psoriatic arthritis patients Anjali Nimesh Nimesh20 Jun 2017 9:38 AM ISTThe results of two studies presented at the Annual European Congress of Rheumatology (EULAR) 2017 press conference revealed promising data supporting...
New medication guidelines for rheumatic disease patients having joint replacement Anjali Nimesh Nimesh20 Jun 2017 1:37 PM ISTIn the first such collaboration of its kind, an expert panel of rheumatologists and orthopedic surgeons has developed guidelines for the perioperative...
TOFACITINIB approved for adults with Psoriatic Arthritis Dr. Kamal Kant Kohli Kohli20 Dec 2017 7:25 PM ISTUnited States Food and Drug Administration (FDA) has approved XELJANZ® (TOFACITINIB) 5 mg twice daily (BID) and XELJANZ® XR (tofacitinib)...
New drugs for inflammatory bowel disease Ruby khatun khatun22 Jan 2018 8:29 PM ISTLas Vegas, NV: 1.6 million Americans suffer from inflammatory bowel disease (IBD) -- which includes Crohn's disease and ulcerative colitis. Currently,...
Tofacitinib and light therapy combo found effective in Vitiligo Anjali Nimesh Nimesh1 Feb 2018 7:15 PM ISTDr.King and his colleagues have successfully treated cases of resistant vitiligo by a new combination therapy comprising of Tofacitinib, an arthritis...
Novel treatment found for disfiguring cutaneous sarcoidosis Vinay Singh singh28 Dec 2018 7:25 PM ISTA new study published in NEJM has reported successful treatment of a patient with disfiguring sarcoidosis with a drug approved for rheumatoid...
Tofacitinib effective in resistant cutaneous Sarcoidosis Vinay Singh singh8 Jan 2019 7:15 PM ISTA new study published in NEJM has demonstrated benefits to treating severe cutaneous sarcoidosis using tofacitinib.Sarcoidosis is an inflammatory...
Daily Tofacitinib controls Rheumatoid Arthritis symptoms and limits structural damage Hina Zahid21 May 2019 7:20 PM ISTDaily Tofacitinib not only controls Rheumatoid Arthritis symptoms but also limits structural damage in RA.According to new study results, Tofacitinib...
Axial Spondyloarthritis: Updated Guidelines by Rheumatology and Spondylitis Organizations Hina Zahid31 Aug 2019 7:00 PM ISTThe American College of Rheumatology, Spondylitis Association of America, and Spondyloarthritis Research and Treatment Network have updated their...
Rheumatoid patients on Tofacitinib have higher shingles risk, finds study Dr. Kamal Kant Kohli Kohli30 Oct 2019 7:10 PM ISTTofacitinib-treated rheumatoid arthritis patients have higher shingles risk, researchers have found. The risk doubled when patients also used...
Topical tofacitinib safe and effective for treatment of refractory vitiligo Medha Baranwal Baranwal1 Jan 2020 7:25 PM ISTUSA: Topical tofacitinib 2% is effective for the treatment of refractory vitiligo, suggests a recent study published in the British Journal of...
Tofacitinib monotherapy effective in rheumatoid arthritis after methotrexate withdrawal Medha Baranwal Baranwal20 Jun 2019 7:25 PM ISTTreatment with tofacitinib extended-release monotherapy was noninferior to tofacitinib extended release plus methotrexate at 48 weeks in patients with...
